Cra Financial Services, LLC Abb Vie Inc. Transaction History

Cra Financial Services, LLC

$519 Million
Q3 2024

A detailed history of Cra Financial Services, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Cra Financial Services, LLC holds 11,322 shares of ABBV stock, worth $2.04 Million. This represents 0.43% of its overall portfolio holdings.

Number of Shares

11,322

Previous 11,336 0.12%

Holding current value

$2.04 Million

Previous $1.94 Million 14.97%

% of portfolio

0.43%

Previous 0.41%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	SELL	$163.84 - $199.33 $2,293 - $2,790	-14 Reduced 0.12%	11,322 $2.24 Million
Q2 2024 Jul 11, 2024	SELL	$154.79 - $180.76 $14,240 - $16,629	-92 Reduced 0.81%	11,336 $1.94 Million
Q1 2024 Apr 17, 2024	BUY	$159.82 - $182.1 $1,598 - $1,821	10 Added 0.09%	11,428 $2.08 Million
Q4 2023 Jan 31, 2024	BUY	$137.6 - $154.97 $3,715 - $4,184	27 Added 0.24%	11,418 $1.77 Million
Q3 2023 Oct 13, 2023	BUY	$133.59 - $154.65 $314,604 - $364,200	2,355 Added 26.06%	11,391 $1.7 Million
Q2 2023 Jul 11, 2023	BUY	$132.51 - $164.9 $21,466 - $26,713	162 Added 1.83%	9,036 $1.22 Million
Q1 2023 Apr 06, 2023	BUY	$144.61 - $166.54 $40,635 - $46,797	281 Added 3.27%	8,874 $1.41 Million
Q4 2022 Jan 24, 2023	SELL	$138.31 - $165.87 $53,525 - $64,191	-387 Reduced 4.31%	8,593 $0
Q3 2022 Oct 21, 2022	SELL	$134.21 - $153.93 $13,421 - $15,393	-100 Reduced 1.1%	8,980 $1.21 Million
Q2 2022 Jul 21, 2022	BUY	$137.62 - $174.96 $2,752 - $3,499	20 Added 0.22%	9,080 $1.39 Million
Q1 2022 Apr 15, 2022	BUY	$131.98 - $163.75 $255,909 - $317,511	1,939 Added 27.23%	9,060 $1.47 Million
Q4 2021 Jan 20, 2022	SELL	$107.43 - $135.93 $5,156 - $6,524	-48 Reduced 0.67%	7,121 $964,000
Q3 2021 Oct 12, 2021	BUY	$106.4 - $120.78 $43,624 - $49,519	410 Added 6.07%	7,169 $773,000
Q2 2021 Jul 23, 2021	BUY	$105.21 - $117.21 $110,260 - $122,836	1,048 Added 18.35%	6,759 $761,000
Q1 2021 Apr 16, 2021	SELL	$102.3 - $112.62 $716 - $788	-7 Reduced 0.12%	5,711 $618,000
Q4 2020 Jan 27, 2021	BUY	$80.49 - $108.67 $25,676 - $34,665	319 Added 5.91%	5,718 $613,000
Q3 2020 Oct 14, 2020	SELL	$85.91 - $100.83 $14,862 - $17,443	-173 Reduced 3.1%	5,399 $473,000
Q2 2020 Jul 22, 2020	BUY	$73.37 - $98.18 $14,600 - $19,537	199 Added 3.7%	5,572 $547,000
Q1 2020 Apr 14, 2020	BUY	$64.5 - $97.79 $19,414 - $29,434	301 Added 5.93%	5,373 $409,000
Q4 2019 Jan 28, 2020	BUY	$72.13 - $90.25 $123,125 - $154,056	1,707 Added 50.73%	5,072 $449,000
Q3 2019 Nov 07, 2019	BUY	$62.98 - $75.72 $19,460 - $23,397	309 Added 10.11%	3,365 $255,000
Q2 2019 Jul 24, 2019	SELL	$65.7 - $83.98 $2,430 - $3,107	-37 Reduced 1.2%	3,056 $222,000
Q1 2019 Apr 15, 2019	BUY	$77.14 - $90.79 $46,129 - $54,292	598 Added 23.97%	3,093 $249,000
Q4 2018 Feb 08, 2019	BUY	$77.85 - $96.01 $194,235 - $239,544	2,495 New	2,495 $230,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cra Financial Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cra Financial Services, LLC with notifications on news.

Account

Cra Financial Services, LLC Abb Vie Inc. Transaction History